ARTICLE | Clinical News
Intuniv guanfacine extended release regulatory update
September 28, 2015 7:00 AM UTC
The European Commission approved an MAA from Shire for once-daily Intuniv guanfacine extended release to treat ADHD in patients ages 6-17 for whom stimulants are not suitable, not tolerated or have be...